本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

INVION LTD

0.080
-0.003-3.61%
成交量:1.00
成交額:0.08
市值:619.83萬
市盈率:-0.76
高:0.080
開:0.080
低:0.080
收:0.083
資料載入中...

公司資料

公司名字:
INVION LTD
交易所:
ASX
成立時間:
2000
員工人數:
4
公司地址:
100 Albert Road,Level 4,Melbourne,Victoria,Australia
郵編:
3205
傳真:
- -
簡介:
Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.